Migraine drug could soothe stubborn facial pain
NCT ID NCT07250984
First seen Jan 10, 2026 · Last updated May 23, 2026 · Updated 16 times
Summary
This study tests if a migraine medicine called ACMP (Eptinezumab) can help people with persistent facial pain that doesn't respond to other treatments. The idea is that the drug may calm overactive pain signals in the face, similar to how it works for migraines. Ten adults with facial pain will receive the drug intravenously, and researchers will measure changes in pain-related disability and blood markers of inflammation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACIAL PAIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pain Therapy Clinic of University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia
Conditions
Explore the condition pages connected to this study.